Patents Assigned to Pulse
  • Patent number: 11201384
    Abstract: In-building antenna apparatus and methods for manufacturing and installing the same. In one embodiment, the antenna apparatus includes a radome cover, a lower flange, an antenna housing, a spring-loaded mount apparatus, a signaling interface, and a plurality of spring arms. Each of the spring arms may include at least one tie-down location. Accordingly, when a removable tie is placed around a plurality of tie-down locations, the antenna apparatus resides in an installation configuration; however, when the removable tie is removed from around the plurality of tie-down locations, the antenna apparatus transitions towards a default configuration. The spring arms may also act as a ground plane for the antenna. Spring-loaded mount apparatus as well as methods of manufacturing and installing the aforementioned antenna apparatus are also disclosed.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: December 14, 2021
    Assignee: Pulse Finland OY
    Inventors: Zack Ge, Jay Yuan
  • Patent number: 11191975
    Abstract: An erythrocyte de-aggregation system includes a band, including a strap and housing securing an iron-cored, micro-coil to an appendage, such as a wrist, of a subject to apply a PEMF into a target vessel in the vascular system of the subject. Typically, all of the blood circulates about the body within a matter of a few minutes, some within seconds, thus treating the entire bloodstream over time. The portable PEMF system intensifies both the concentration of electromagnetic flux per unit area, as well as the depth of penetration into the body. The portable PEMF systems relies on the body's circulatory system to eventually pass the body's entire volume of blood past it over a period of time.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: December 7, 2021
    Assignee: Pulse, LLC
    Inventors: Gregory S. Anderson, Kade E. Huntsman, Dale C. Gledhill, Marc E. Jackson
  • Publication number: 20210276902
    Abstract: A wastewater treatment system includes a blower providing air to an aerator and a low pressure pulsed air mixer. The invention generally relates to a wastewater treatment system and more particularly to a wastewater treatment system to eliminate biological and nutrient contaminants from wastewater.
    Type: Application
    Filed: September 6, 2019
    Publication date: September 9, 2021
    Applicant: Pulsed Burst Systems, LLC
    Inventors: Kenneth E. Neu, Charles Otis, Trevor Ghylin
  • Patent number: 11051882
    Abstract: A sub-microsecond pulsed electric field generator is disclosed. The field generator includes a controller, which generates a power supply control signal and generates a pulse generator control signal, and a power supply, which receives the power supply control signal and generates one or more power voltages based on the received power supply control signal. The field generator also includes a pulse generator which receives the power voltages and the pulse generator control signal, and generates one or more pulses based on the power voltages and based on the pulse generator control signal. In some embodiments, the controller receives feedback signals representing a value of a characteristic of or a result of the pulses and generates at least one of the power supply control signal and the pulse generator control signal based on the received feedback signals.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: July 6, 2021
    Assignee: Pulse Biosciences, Inc.
    Inventors: Shu Xiao, Brian G. Athos, Mark P. Kreis, David J. Danitz, Darrin R. Uecker
  • Patent number: 11051871
    Abstract: Nanosecond pulsed electric field (nsPEF) treatments of a tumor are adjusted based on a size and type of the tumor to stimulate an immune response against the tumor and other tumors in the subject. Calreticulin expression on tumor cells can be detected to confirm treatment. An immune response biomarker can be measured, and further nsPEF treatments can be performed if needed to stimulate or further stimulate the immune response. Cancers that have metastasized may be treated by directly treating a tumor that is most accessible. The treatment can be combined with CD47-blocking antibodies, doxorubicin, CTLA-4-blocking antibodies, and/or PD-1-blocking antibodies. Electrical characteristics of nsPEF treatments can be based on the size, type, and/or strength of tumors and/or a quantity of tumors in the subject.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: July 6, 2021
    Assignee: Pulse Biosciences, Inc.
    Inventors: Richard Lee Nuccitelli, Pamela S. Nuccitelli, Joanne Lum, Kaying Lui, Brian G. Athos, Mark P. Kreis, Zachary R. Mallon, Jon Berridge
  • Publication number: 20210196375
    Abstract: A sub-microsecond pulsed electric field generator is disclosed. The field generator includes a controller, which generates a power supply control signal and generates a pulse generator control signal, and a power supply, which receives the power supply control signal and generates one or more power voltages based on the received power supply control signal. The field generator also includes a pulse generator which receives the power voltages and the pulse generator control signal, and generates one or more pulses based on the power voltages and based on the pulse generator control signal. In some embodiments, the controller receives feedback signals representing a value of a characteristic of or a result of the pulses and generates at least one of the power supply control signal and the pulse generator control signal based on the received feedback signals.
    Type: Application
    Filed: March 9, 2021
    Publication date: July 1, 2021
    Applicant: Pulse Biosciences, Inc.
    Inventors: Shu Xiao, Brian G. Athos, Mark P. Kreis, David J. Danitz, Darrin R. Uecker
  • Publication number: 20210146129
    Abstract: A pulse generation system is disclosed. The pulse generation system includes a controller, an output terminal, and a plurality of pulse generator circuits. The controller is configured to cause a driving signal pulse to be transmitted to any selected one or more of the pulse generator circuits, and to cause the driving signal pulse to not be transmitted to any selected one or more other pulse generator circuits. Each of the pulse generator circuits is configured to generate an output voltage pulse at the output terminal in response to the driving signal pulse being transmitted thereto.
    Type: Application
    Filed: January 26, 2021
    Publication date: May 20, 2021
    Applicant: Pulse Biosciences, Inc.
    Inventors: Brian G. Athos, Shu Xiao, David J. Danitz, Mark P. Kreis, Darrin R. Uecker
  • Patent number: 11000589
    Abstract: Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one aspect, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: May 11, 2021
    Assignee: Pulse Therapeutics, Inc.
    Inventor: Francis M. Creighton
  • Patent number: 10955580
    Abstract: Tools and methods for measuring resistivity are provided. The tool for measuring resistivity in a formation comprises a receiver module comprising a first electromagnetic signal receiver and a second electromagnetic signal receiver; a first electromagnetic signal transmitter removably coupled to one longitudinal end of the receiver module; a second electromagnetic signal transmitter removably coupled to the other longitudinal end of the receiver module; and each of the first and the second electromagnetic signal receivers configured to receive electromagnetic signals propagating in the formation from the first and the second electromagnetic signal transmitters.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: March 23, 2021
    Assignee: Pulse Directional Technologies Inc.
    Inventors: Karl Edler, Steve Braisher
  • Publication number: 20210068754
    Abstract: Apparatus and methods are disclosed for providing a strap configured to be worn around a torso and situate a circuit offset from other garments worn by the strap user. For example, a torso strap can be provided that has an offset portion or lobe that situates a circuit offset from another portion of the torso strap. In some examples, a torso strap includes a narrower portion adapted to encircle the torso, a wider portion configured to situate a circuit at least partially offset from the narrower portion of the strap, a sensor coupled to a first surface of the strap, and a wire being in communication with the circuit and the sensor. In some examples, a method includes providing such an apparatus and using the apparatus to monitor health characteristics of the user, including pulse, heart rate, temperature, blood oxygen, velocity, displacement, attitude, time, or moisture.
    Type: Application
    Filed: September 10, 2020
    Publication date: March 11, 2021
    Applicant: Beyond Pulse, LLC
    Inventor: Nya Kamhi
  • Publication number: 20210065092
    Abstract: The present invention includes a business intelligence system that scrapes data from various available WAN resources to aggregate captured data that supplies intelligence concerning contract activities, contract events, and social commentary concerning the same.
    Type: Application
    Filed: August 27, 2019
    Publication date: March 4, 2021
    Applicant: The Pulse of GovCon, LLC
    Inventors: Amber Hart, Lisa Mundt
  • Publication number: 20210038282
    Abstract: A pulse generator discharge circuit is disclosed. The circuit includes one or more discharge stages, each discharge stage including a plurality of control input terminals. The circuit also includes first and second discharge terminals, and a plurality of serially connected switches electrically connected between the first and second discharge terminals, where a conductive state of each of the switches is controlled by a control signal. The circuit also includes a plurality of inductive elements configured to generate the control signals for the serially connected switches, where each inductive element is configured to generate a control signal for one of the serially connected switches in response to one or more input signals at one or more of the control input terminals, and where each of the serially connected switches is configured to receive a control signal from a respective one of the inductive elements.
    Type: Application
    Filed: October 28, 2020
    Publication date: February 11, 2021
    Applicant: Pulse Biosciences, Inc.
    Inventors: Brian G. Athos, Darrin R. Uecker, Shu Xiao
  • Publication number: 20200384014
    Abstract: Described herein are methods of treating pulmonary hypertension by maintaining dosing frequency and/or minimizing skipped breaths during pulsed administration of inhaled nitric oxide.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 10, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah QUINN, Parag SHAH, Martin DEKKER
  • Patent number: 10850095
    Abstract: Methods and apparatuses for treating a tissue with an electric treatment by rotating a pattern of electrodes partway through a treatment is disclosed. Also described herein are methods and apparatuses to treat tissue, including treating skin disorders, by selectively de-nucleating epidermal cells without provoking a significant inflammatory response, e.g., without increasing the density of leukocytes in the treated skin, and without affecting the non-cellular components of the dermis.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 1, 2020
    Assignee: Pulse Biosciences, Inc.
    Inventors: Edward Ebbers, David J. Danitz, Richard L. Nuccitelli, Darrin R. Uecker, Cameron D. Hinman, Kevin L. Moss
  • Publication number: 20200360425
    Abstract: Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension, improving exercise capacity and/or reducing oxygen desaturation in a patient.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Publication number: 20200360647
    Abstract: Described herein are methods of using inhaled nitric oxide for improving and/or maintaining right ventricular function and/or left ventricular function. Some methods relate to the long-term administration of inhaled nitric oxide to a patient with pulmonary hypertension.
    Type: Application
    Filed: August 29, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Patent number: 10813997
    Abstract: A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In one embodiment, the invention relates to the control of magnetic particles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Examples of vascular occlusions targeted by the system include, but are not limited to, atherosclerotic plaques, including fibrous caps, fatty buildup, coronary occlusions, arterial stenosis, restenosis, vein thrombi, arterial thrombi, cerebral thrombi, embolisms, hemorrhages, other blood clots, and very small vessels.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: October 27, 2020
    Assignee: Pulse Therapeutics, Inc.
    Inventor: Francis M. Creighton
  • Publication number: 20200315687
    Abstract: Nanosecond pulsed electric field (nsPEF) treatments of a tumor are adjusted based on a size and type of the tumor to stimulate an immune response against the tumor and other tumors in the subject. Calreticulin expression on tumor cells can be detected to confirm treatment. An immune response biomarker can be measured, and further nsPEF treatments can be performed if needed to stimulate or further stimulate the immune response. Cancers that have metastasized may be treated by directly treating a tumor that is most accessible. The treatment can be combined with CD47-blocking antibodies, doxorubicin, CTLA-4-blocking antibodies, and/or PD-1-blocking antibodies. Electrical characteristics of nsPEF treatments can be based on the size, type, and/or strength of tumors and/or a quantity of tumors in the subject.
    Type: Application
    Filed: June 23, 2020
    Publication date: October 8, 2020
    Applicant: Pulse Biosciences, Inc.
    Inventors: Richard Lee Nuccitelli, Pamela S. Nuccitelli, Joanne Lum, Kaying Lui, Brian G. Athos, Mark P. Kreis, Zachary R. Mallon, Jon Berridge
  • Patent number: 10742595
    Abstract: A system includes a virtual private network (VPN) gateway and a client device. The VPN gateway receives a domain name system response through a physical coding sublayer. The VPN gateway fetches a fully qualified domain name corresponding to the domain name system response, and fetches one or more access control list rules from an access control list table for a specific user account. The VPN gateway installs an Internet protocol (IP) address in the access control list table for each access control list rule and handles requested data traffic to the IP address. The client device creates a virtual tunnel interface route with a port of a transmission control protocol (TCP) listener device and parses the domain name system response. The client device updates a domain name system cache with the fully qualified domain name and the IP address and sends unencrypted network traffic over the virtual tunnel interface route.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: August 11, 2020
    Assignee: Pulse Secure, LLC
    Inventors: Shanavas Kottikal, Prabhath Thankappan, John Alappattu Varudunny, George Matthew Koikara
  • Patent number: D938464
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: December 14, 2021
    Assignee: Pulse Medical Imaging Technology (Shanghai) Co. Ltd.
    Inventors: Shengxian Tu, Jun Pu, Xinkai Qu